UROLOGIC NEOPLASMS
Clinical trials for UROLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for UROLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a combination of two drugs, tucatinib and trastuzumab, in people with advanced solid tumors that have HER2 alterations. The goal is to see if the treatment can shrink or control the cancer. About 217 participants with various cancer types, including lung, uterine…
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for rare kidney cancer: targeted drug shows promise in Late-Stage trial
Disease control OngoingThis study tests a new drug called savolitinib against a standard treatment (sunitinib) in people with a rare type of kidney cancer (papillary renal cell carcinoma) that has spread and cannot be removed by surgery. The cancer must have a specific genetic change (MET-driven). The …
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 15:59 UTC